| Frequency and risk factors for extraintestinal manifestations in the Swiss inflammatory bowel disease cohort SR Vavricka, L Brun, P Ballabeni, V Pittet, BMP Vavricka, J Zeitz, G Rogler, ... Official journal of the American College of Gastroenterology| ACG 106 (1 …, 2011 | 723 | 2011 |
| Symptoms of depression and anxiety are independently associated with clinical recurrence of inflammatory bowel disease A Mikocka-Walus, V Pittet, JB Rossel, R von Känel, C Anderegg, ... Clinical Gastroenterology and Hepatology 14 (6), 829-835. e1, 2016 | 341 | 2016 |
| Chronological order of appearance of extraintestinal manifestations relative to the time of IBD diagnosis in the Swiss inflammatory bowel disease cohort SR Vavricka, G Rogler, C Gantenbein, M Spoerri, M Prinz Vavricka, ... Inflammatory bowel diseases 21 (8), 1794-1800, 2015 | 296 | 2015 |
| Systematic evaluation of risk factors for diagnostic delay in inflammatory bowel disease SR Vavricka, SM Spigaglia, G Rogler, V Pittet, P Michetti, C Felley, ... Inflammatory bowel diseases 18 (3), 496-505, 2012 | 283 | 2012 |
| Diagnostic delay in Crohn's disease is associated with a complicated disease course and increased operation rate AM Schoepfer, MA Dehlavi, N Fournier, E Safroneeva, A Straumann, ... Official journal of the American College of Gastroenterology| ACG 108 (11 …, 2013 | 248 | 2013 |
| The role and utility of faecal markers in inflammatory bowel disease FS Lehmann, E Burri, C Beglinger Therapeutic advances in gastroenterology 8 (1), 23-36, 2015 | 210 | 2015 |
| Cohort profile: the Swiss inflammatory bowel disease cohort study (SIBDCS) V Pittet, P Juillerat, C Mottet, C Felley, P Ballabeni, B Burnand, P Michetti, ... International journal of epidemiology 38 (4), 922-931, 2009 | 160 | 2009 |
| Pain in IBD patients: very frequent and frequently insufficiently taken into account J Zeitz, M Ak, S Müller-Mottet, S Scharl, L Biedermann, N Fournier, P Frei, ... PloS one 11 (6), e0156666, 2016 | 152 | 2016 |
| Serum protein electrophoresis: an underused but very useful test SR Vavricka, E Burri, C Beglinger, L Degen, M Manz Digestion 79 (4), 203-210, 2009 | 149 | 2009 |
| Value of fecal calprotectin in the evaluation of patients with abdominal discomfort: an observational study M Manz, E Burri, C Rothen, N Tchanguizi, C Niederberger, L Rossi, ... BMC gastroenterology 12, 1-9, 2012 | 140 | 2012 |
| Extraintestinal manifestations of pediatric inflammatory bowel disease: prevalence, presentation, and anti-TNF treatment T Greuter, F Bertoldo, R Rechner, A Straumann, L Biedermann, J Zeitz, ... Journal of pediatric gastroenterology and nutrition 65 (2), 200-206, 2017 | 139 | 2017 |
| The use of fecal calprotectin as a biomarker in gastrointestinal disease E Burri, C Beglinger Expert review of gastroenterology & hepatology 8 (2), 197-210, 2014 | 120 | 2014 |
| Sodium chloride vs. sodium bicarbonate for the prevention of contrast medium-induced nephropathy: a randomized controlled trial T Klima, A Christ, I Marana, S Kalbermatter, H Uthoff, E Burri, S Hartwiger, ... European heart journal 33 (16), 2071-2079, 2012 | 117 | 2012 |
| Impact of the early use of immunomodulators or TNF antagonists on bowel damage and surgery in Crohn's disease E Safroneeva, SR Vavricka, N Fournier, V Pittet, L Peyrin‐Biroulet, ... Alimentary pharmacology & therapeutics 42 (8), 977-989, 2015 | 110 | 2015 |
| Faecal calprotectin–a useful tool in the management of inflammatory bowel disease E Burri, C Beglinger Swiss medical weekly 142 (1314), w13557-w13557, 2012 | 104 | 2012 |
| Vegetarian or gluten-free diets in patients with inflammatory bowel disease are associated with lower psychological well-being and a different gut microbiota, but no beneficial … P Schreiner, B Yilmaz, JB Rossel, Y Franc, B Misselwitz, M Scharl, J Zeitz, ... United European gastroenterology journal 7 (6), 767-781, 2019 | 103 | 2019 |
| Anti-TNF treatment for extraintestinal manifestations of inflammatory bowel disease in the Swiss IBD Cohort Study SR Vavricka, M Gubler, C Gantenbein, M Spoerri, F Froehlich, F Seibold, ... Inflammatory bowel diseases 23 (7), 1174-1181, 2017 | 102 | 2017 |
| Association of alterations in intestinal microbiota with impaired psychological function in patients with inflammatory bowel diseases in remission F Humbel, JH Rieder, Y Franc, P Juillerat, M Scharl, B Misselwitz, ... Clinical gastroenterology and hepatology 18 (9), 2019-2029. e11, 2020 | 97 | 2020 |
| Treatment algorithms for Crohn’s disease MC Sulz, E Burri, P Michetti, G Rogler, L Peyrin-Biroulet, F Seibold Digestion 101 (Suppl. 1), 43-57, 2020 | 92 | 2020 |
| Treatment algorithm for mild and moderate-to-severe ulcerative colitis: an update E Burri, MH Maillard, AM Schoepfer, F Seibold, G Van Assche, P Rivière, ... Digestion 101 (Suppl. 1), 2-15, 2020 | 91 | 2020 |
